Select Page

Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries, announced today their partnership focused on improving drug development for paediatric patients.

 

Share:
ClinChoice Acquires CROMSOURCE, Expanding its Global Presence

On March 1st, 2023 ClinChoice acquired CROMSOURCE, strengthening its global network and deepening its full-service capabilities. Strategically, the acquisition will expand ClinChoice’s coverage in Europe and in US to better meet its global clients’ needs in clinical development and staffing solution services. This merger also expands its data science technology offerings in many areas including decentralized clinical trials and risk-based monitoring.